Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Vera Therapeutics, Inc. (VERA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
14.20+0.58 (+4.26%)
At close: 04:00PM EDT
14.20 0.00 (0.00%)
After hours: 05:00PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 6/22/2022
Current
3/31/202212/31/20219/30/20216/30/2021
Market Cap (intraday)
388.58M635.77M568.54M369.17M282.14M
Enterprise Value
250.42M561.02M514.89M315.51M228.49M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
2.899.146.654.01N/A
Enterprise Value/Revenue
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA
-5.60-33.08-30.66-41.78-67.46

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-1.39%
S&P500 52-Week Change 3-8.83%
52 Week High 337.11
52 Week Low 312.28
50-Day Moving Average 316.90
200-Day Moving Average 320.54

Share Statistics

Avg Vol (3 month) 392.04k
Avg Vol (10 day) 3109.65k
Shares Outstanding 526.77M
Implied Shares Outstanding 6N/A
Float 811.02M
% Held by Insiders 18.52%
% Held by Institutions 189.62%
Shares Short (May 30, 2022) 4399.98k
Short Ratio (May 30, 2022) 43.84
Short % of Float (May 30, 2022) 43.39%
Short % of Shares Outstanding (May 30, 2022) 41.48%
Shares Short (prior month Apr 28, 2022) 4422.62k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-26.85%
Return on Equity (ttm)-49.79%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -46.41M
Net Income Avi to Common (ttm)-44.98M
Diluted EPS (ttm)-2.32
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)150.94M
Total Cash Per Share (mrq)5.57
Total Debt (mrq)12.78M
Total Debt/Equity (mrq)9.51
Current Ratio (mrq)7.90
Book Value Per Share (mrq)4.97

Cash Flow Statement

Operating Cash Flow (ttm)-28.57M
Levered Free Cash Flow (ttm)-20.9M
Advertisement
Advertisement